Exacerbations on benralizumab for severe asthma are non-eosinophilic

Causes of exacerbations in patients on benralizumab for severe eosinophilic asthma are related to infection rather than eosinophilic inflammation, according to results published in The Lancet Respiratory Medicine.“The most interesting finding was that eosinophils remained fully depleted during exacerbations in patients treated with benralizumab, not only in the blood but also within the